Completed
Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne
NCT02998671
- Conditions
- Acne Vulgaris, Acneiform Eruptions, Sebaceous Gland Diseases, +2 more
- Locations
-
- Novartis Investigative Site Culver City, California, United States
- Novartis Investigative Site Sacramento, California, United States
- Novartis Investigative Site Austin, Texas, United States
- Novartis Investigative Site Bonn, Germany